Emma Walmsley, GlaxoSmithKline CEO (Fang Zhe/Xinhua/Alamy Live News)
GSK's consumer health spinoff Haleon preps launch with $12B+ in debt
GSK’s consumer health spinoff Haleon will make its big debut in just over a week — but with some serious debt in tow, according to the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
